-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Athira Pharma, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2019 to Q3 2024.
- Athira Pharma, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$29.6M, a 15.5% increase year-over-year.
- Athira Pharma, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$114M, a 11.6% increase year-over-year.
- Athira Pharma, Inc. annual Operating Income (Loss) for 2023 was -$125M, a 20.6% decline from 2022.
- Athira Pharma, Inc. annual Operating Income (Loss) for 2022 was -$104M, a 62.5% decline from 2021.
- Athira Pharma, Inc. annual Operating Income (Loss) for 2021 was -$64M, a 220% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)